Q-omics provides the consensus-scored MTND5P11 profile across patient tissues and cancer cell-line models. MTND5P11 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, MTND5P11 is differentially expressed in 8, with the highest sampling consensus in HNSC. Additionally, MTND5P11 RNA expression shows 14,902 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight ACC, and HNSC as cancer lineages where MTND5P11 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MTND5P11 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MTND5P11 survival associations across molecular data types. MTND5P11 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MTND5P11 RNA expression–survival associations across cancer types. High MTND5P11 expression shows unfavorable associations in LUAD, but favorable associations in ACC, KIRP, PAAD, HNSC and BLCA. The ACC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for MTND5P11 RNA expression.
This table summarizes MTND5P11 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for MTND5P11. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MTND5P11 shows lower tumor expression in HNSC, LUSC, KIRP, BLCA and LUAD and higher tumor expression in KICH. The HNSC box plot shows higher MTND5P11 RNA expression in normal versus tumor tissue (log2 FC = −0.503, t-test p < 0.001).
This table shows molecular features associated with MTND5P11 in patient tissues and cancer cell lines. In patient samples, MTND5P11 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
